155 related articles for article (PubMed ID: 11316866)
41. An in vitro method for predicting in vivo oral bioavailability of novel immunosuppressive drugs.
Dias VC; Yatscoff RW
Clin Biochem; 1996 Feb; 29(1):43-9. PubMed ID: 8929823
[TBL] [Abstract][Full Text] [Related]
42. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
Levy AE; Alexander JW; Babcock GF
Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
[TBL] [Abstract][Full Text] [Related]
43. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
44. Rapamycin even when combined with cyclosporine attenuates tumor growth but does not induce regression of established walker sarcomas.
Silva SL; Silva SF; Farias IN; Mota RS; Carvalho RA; Moraes MO; Moraes ME; Campos Hde H
Transplant Proc; 2004 May; 36(4):934-7. PubMed ID: 15194323
[TBL] [Abstract][Full Text] [Related]
45. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
46. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.
Murgia MG; Jordan S; Kahan BD
Kidney Int; 1996 Jan; 49(1):209-16. PubMed ID: 8770969
[TBL] [Abstract][Full Text] [Related]
47. Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy.
Gleissner CA; Doesch A; Ehlermann P; Koch A; Sack FU; Katus HA; Dengler TJ
Am J Transplant; 2006 Nov; 6(11):2750-8. PubMed ID: 16939514
[TBL] [Abstract][Full Text] [Related]
48. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Hagar HH; El Etter E; Arafa M
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
[TBL] [Abstract][Full Text] [Related]
49. Cyclosporine A toxicity in association with reduced renal mass.
Güray M; Sarioğlu S; Türkmen M; Yilmaz O; Ellidokuz H; Gelal A; Işlekel H; Coker A; Ozer E
Transplant Proc; 2003 Dec; 35(8):3128-33. PubMed ID: 14697995
[TBL] [Abstract][Full Text] [Related]
50. The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigs.
Cibulskyte D; Pedersen M; Hjelm-Poulsen J; Hansen HE; Madsen M; Mortensen J
Int Immunopharmacol; 2006 Apr; 6(4):627-34. PubMed ID: 16504926
[TBL] [Abstract][Full Text] [Related]
51. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
[TBL] [Abstract][Full Text] [Related]
52. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
Satyanarayana PS; Chopra K
Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
[TBL] [Abstract][Full Text] [Related]
53. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
Sass DA; Rucinski B; Bryer HP; Mann GN; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
[TBL] [Abstract][Full Text] [Related]
54. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine.
Hartner WC; Van der Werf WJ; Lodge JP; Gilchrist B; De Fazio SR; Markees TG; Yatko C; Monaco AP; Gozzo JJ
Transplantation; 1995 Dec; 60(11):1347-50. PubMed ID: 8525533
[TBL] [Abstract][Full Text] [Related]
55. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity.
Padi SS; Chopra K
Pharmacol Res; 2002 May; 45(5):413-20. PubMed ID: 12123630
[TBL] [Abstract][Full Text] [Related]
56. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
[TBL] [Abstract][Full Text] [Related]
57. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
58. Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
Isnard Bagnis C; Tezenas du Montcel S; Beaufils H; Jouanneau C; Jaudon MC; Maksud P; Mallet A; LeHoang P; Deray G
J Am Soc Nephrol; 2002 Dec; 13(12):2962-8. PubMed ID: 12444215
[TBL] [Abstract][Full Text] [Related]
59. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation.
Schmitz V; Klawitter J; Bendrick-Peart J; Schoening W; Puhl G; Haschke M; Klawitter J; Consoer J; Rivard CJ; Chan L; Tran ZV; Leibfritz D; Christians U
Nephron Exp Nephrol; 2009; 111(4):e80-91. PubMed ID: 19293597
[TBL] [Abstract][Full Text] [Related]
60. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
